Unexpected toxicity of combination thalidomide and interferon alpha-2a treatment in metastatic renal cell carcinoma

J Clin Oncol. 2002 Mar 1;20(5):1429-30. doi: 10.1200/JCO.2002.20.5.1429.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / adverse effects
  • Kidney Neoplasms / drug therapy*
  • Recombinant Proteins
  • Thalidomide / administration & dosage*
  • Thalidomide / adverse effects

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Thalidomide